Plain-English translation of NCT06930508 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This research study is testing whether family planning clinics can offer HIV pre-exposure prophylaxis (PrEP) โ a preventive medication that reduces the risk of HIV infection โ to patients who may benefit from it. Researchers want to understand whether adding this service to regular family planning visits works well, is acceptable to patients, and fits into how clinics already operate.
Right now, HIV prevention medication is not widely available in family planning clinics, even though these clinics serve many people at higher risk for HIV. This study aims to figure out how to bring this medication option to patients in a way that works for busy clinics and feels right for the people they serve.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
A research assistant will explain the study to you when you come for your family planning visit. If you agree to participate, you'll be screened by a clinic doctor to see if the HIV prevention medication might be right for you. You'll also answer survey questions about your thoughts on the screening and medication service. The whole process is designed to fit into your regular clinic visit without taking much extra time.
AI-generated summary from trial data ยท Jul 8, 2026 ยท Not medical advice
United States
Women and Infants Hospital of Rhode Island
Collaborators
Advance RI CTR
Enrollment target
~83 participants
Started
May 2026
Primary completion
July 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
16 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Benjamin P Brown, MD, MS
Women and Infants Hospital of Rhode Island
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.